SCHEMBL18558372

SCHEMBL18558372

Cc1ccc(Cc2cnns2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 2/20 0.47
PRMT6 Q96LA8 1/20 0.46
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 2/20 0.35
TP53 P04637 1/20 0.35
KDM4C Q9H3R0 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10017405 0.79 PRMT6 (0.65) ADRA1DPRMT6ALDH1A1LMNATHRB
SCHEMBL18719410 0.70 PRMT6 (0.54) ADRA1DPRMT6ALDH1A1LMNATHRB
SCHEMBL20461843 0.70 PRMT6 (0.48) ADRA1DPRMT6ALDH1A1THRBTP53
SCHEMBL26542057 0.68 PRMT6 (0.52) ADRA1DPRMT6ALDH1A1THRBTP53
SCHEMBL1681056 0.68 PRMT6 (0.52) ADRA1DPRMT6ALDH1A1THRBTP53
SCHEMBL1681003 0.68 PRMT6 (0.52) ADRA1DPRMT6ALDH1A1THRBTP53
SCHEMBL14038643 0.66
SCHEMBL19646466 0.66
SCHEMBL14864810 0.66 ADRA1D (0.46) ADRA1DPRMT6ALDH1A1LMNATHRB
SCHEMBL21386931 0.65 PRMT6 (0.48) ADRA1DPRMT6ALDH1A1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580438-B2 Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders 4SC DISCOVERY GMBH (DE) 2017-02-28 US disclosed